KLF5 typically supports proliferation in nontransformed cells, providing a growth advantage (Bateman et al., 2004; Chanchevalap et al., 2004; Sun et al., 2001), and has been shown to induce cisplatin resistance in breast cancer (Li et al., 2017). This evidence concerns the gene KLF5 and breast carcinoma.